Drug Shortage Report for APO-MONTELUKAST

Last updated on 2020-04-07 History
Report ID 72357
Drug Identification Number 02377616
Brand name APO-MONTELUKAST
Common or Proper name MONTELUKAST
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) MONTELUKAST
Strength(s) 5MG
Dosage form(s) TABLET (CHEWABLE)
Route of administration ORAL
Packaging size 30 BLS
ATC code R03DC
ATC description OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-01-14
Estimated end date Unknown
Actual end date 2020-04-03
Shortage status Resolved
Updated date 2020-04-07
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v16 2020-04-07 French Compare
v15 2020-04-07 English Compare
v14 2020-01-29 French Compare
v13 2020-01-29 English Compare
v12 2019-10-29 French Compare
v11 2019-10-29 English Compare
v10 2019-08-19 French Compare
v9 2019-08-19 English Compare
v8 2019-07-02 French Compare
v7 2019-07-02 English Compare
v6 2019-04-26 French Compare
v5 2019-04-26 English Compare
v4 2019-04-01 French Compare
v3 2019-04-01 English Compare
v2 2019-01-15 French Compare
v1 2019-01-15 English Compare

Showing 1 to 16 of 16